Matas A/S
Short position disclosed on May 29, 2026.
1.28% of the capital sold short
2 disclosing funds
174 disclosures on record
DK0060497295 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
January 9, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Two Sigma Investments, LP | 0.69% | new | May 29, 2026 | |
| AQR Capital Management, LLC | 0.59% | new | May 26, 2026 |
On the other side: the funds that hold Matas A/S Titelia
History of disclosures
Other companies sold short in Denmark
- Zealand Pharma A/S 6.75% of the capital sold short
- GN Store Nord A/S 4.81% of the capital sold short
- Ambu A/S 4.00% of the capital sold short
- Pandora A/S 2.25% of the capital sold short
- Carlsberg A/S 1.90% of the capital sold short
- Demant A/S 1.89% of the capital sold short
- Netcompany Group A/S 1.58% of the capital sold short
- Aquaporin A/S 1.51% of the capital sold short
- Noble Corporation Plc 1.17% of the capital sold short
- Novozymes A/S 1.00% of the capital sold short
- ChemoMetec A/S 0.92% of the capital sold short
- Coloplast A/S 0.79% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Matas A/S, source Finanstilsynet, data as at May 29, 2026, https://www.quivad.com/action/matas-a-s?page=4